LYVE1 and lung carcinoma: However, in lung cancer, which is thought to share overlapping etiologic features, TDGF1 (increased in greater decliners) predicts poor progression-free survival51, while LYVE1 (increased in lesser decliners) is associated with reduced metastasis and mortality52.